Last update:

Dermatology news

New research challenges beliefs about 'safe' times to be in the sun

A QIMR Berghofer study has revealed that short periods outdoors during hours of low sunlight can cause skin damage and contribute to skin cancer risk.

Study reveals how early-life cellular process helps shape lifelong immune health

Researchers at Hospital for Special Surgery (HSS) have uncovered a critical link between the immune system in early life and its function in adulthood. The study, published in Science Immunology, identifies a new role for ...

Psoriasis is linked to impairment of some sleep domains

Higher psoriasis (PsO) disease activity is independently associated with impairment in specific sleep domains, but not global sleep quality, according to a study published online May 29 in the Journal of Clinical Medicine.

Barbers may help prevent skin cancer

Could your barber help prevent skin cancer? A new study by the University of Portsmouth suggests that barbers could play a significant role in the early detection and prevention of skin cancer among men, opening a new community-based ...

Q&A: Researcher provides insights into melanoma prognosis

Each year, more than 6,000 Swedes are diagnosed with melanoma. Melanoma is a form of skin cancer that, if detected late, can be fatal. Not all melanomas behave in the same way. A new doctoral thesis from Karolinska Institutet ...

Melanoma cases and deaths highest among Florida's older adults

Florida's year-round sunshine and intense ultraviolet (UV) exposure help drive one of the nation's heaviest skin cancer burdens, with older adults shouldering much of the impact. A new study from Florida Atlantic University's ...

Peach fuzz may hold clues to new chronic itch treatments

Working with mouse models, research led by the University of Michigan has revealed previously hidden biology of how touch-sensitive hairs create itching sensations. This fundamental discovery opens new avenues to better understand ...

FDA approves Icotyde for moderate-to-severe plaque psoriasis

The U.S. Food and Drug Administration has approved Johnson & Johnson's Icotyde (icotrokinra), an interleukin-23 (IL-23) receptor antagonist, for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric ...

Math can tell you how to manage your eczema

Anyone with a chronic illness understands the struggle of living with a disease that is deeply unpredictable. Many such illnesses are characterized by long periods of remission broken up by sudden, debilitating flare-ups. ...

The 'itch-to-brain' circuit, neural change and depression

People who suffer from chronic itching in the form of atopic dermatitis (AD) are seven times more likely to develop a major depressive disorder. This link is well established, but the "why" remains elusive. Are the depressive ...

Sun smart kids have 50% fewer moles and a lower melanoma risk

A long-running Queensland study has found children today are developing significantly fewer moles than kids 25 years ago, with predictions of a major reduction in future melanoma risk. The Brisbane Twin Nevus Study, led by ...

Painless skin patch offers new way to monitor immune health

Researchers at The Jackson Laboratory (JAX), in collaboration with the Massachusetts Institute of Technology (MIT), have developed the first bandage-like microneedle patch that can sample the body's immune responses painlessly ...